Global Hereditary Angioedema Treatment Sales Market Report 2021

Global Hereditary Angioedema Treatment Sales Market Report 2021

Table of Contents
1 Hereditary Angioedema Treatment Market Overview
1.1 Hereditary Angioedema Treatment Product Scope
1.2 Hereditary Angioedema Treatment Segment by Type
1.2.1 Global Hereditary Angioedema Treatment Sales by Type (2016 & 2021 & 2027)
1.2.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
1.2.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
1.2.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
1.2.5 Others (Conventional Drugs, Pipeline Drugs)
1.3 Hereditary Angioedema Treatment Segment by Application
1.3.1 Global Hereditary Angioedema Treatment Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others (online pharmacies, mail pharmacies)
1.4 Hereditary Angioedema Treatment Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hereditary Angioedema Treatment Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hereditary Angioedema Treatment Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hereditary Angioedema Treatment Price Trends (2016-2027)
2 Hereditary Angioedema Treatment Estimates and Forecasts by Region
2.1 Global Hereditary Angioedema Treatment Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hereditary Angioedema Treatment Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hereditary Angioedema Treatment Sales Market Share by Region (2016-2021)
2.2.2 Global Hereditary Angioedema Treatment Revenue Market Share by Region (2016-2021)
2.3 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hereditary Angioedema Treatment Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hereditary Angioedema Treatment Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
2.4.2 Europe Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
2.4.3 China Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
2.4.4 Japan Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
2.4.6 India Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
3 Global Hereditary Angioedema Treatment Competition Landscape by Players
3.1 Global Top Hereditary Angioedema Treatment Players by Sales (2016-2021)
3.2 Global Top Hereditary Angioedema Treatment Players by Revenue (2016-2021)
3.3 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2020)
3.4 Global Hereditary Angioedema Treatment Average Price by Company (2016-2021)
3.5 Manufacturers Hereditary Angioedema Treatment Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hereditary Angioedema Treatment Market Size by Type
4.1 Global Hereditary Angioedema Treatment Historic Market Review by Type (2016-2021)
4.1.1 Global Hereditary Angioedema Treatment Sales Market Share by Type (2016-2021)
4.1.2 Global Hereditary Angioedema Treatment Revenue Market Share by Type (2016-2021)
4.1.3 Global Hereditary Angioedema Treatment Price by Type (2016-2021)
4.2 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Type (2022-2027)
4.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Type (2022-2027)
4.2.3 Global Hereditary Angioedema Treatment Price Forecast by Type (2022-2027)
5 Global Hereditary Angioedema Treatment Market Size by Application
5.1 Global Hereditary Angioedema Treatment Historic Market Review by Application (2016-2021)
5.1.1 Global Hereditary Angioedema Treatment Sales Market Share by Application (2016-2021)
5.1.2 Global Hereditary Angioedema Treatment Revenue Market Share by Application (2016-2021)
5.1.3 Global Hereditary Angioedema Treatment Price by Application (2016-2021)
5.2 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Application (2022-2027)
5.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Application (2022-2027)
5.2.3 Global Hereditary Angioedema Treatment Price Forecast by Application (2022-2027)
6 North America Hereditary Angioedema Treatment Market Facts & Figures
6.1 North America Hereditary Angioedema Treatment Sales by Company
6.1.1 North America Hereditary Angioedema Treatment Sales by Company (2016-2021)
6.1.2 North America Hereditary Angioedema Treatment Revenue by Company (2016-2021)
6.2 North America Hereditary Angioedema Treatment Sales Breakdown by Type
6.2.1 North America Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
6.2.2 North America Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
6.3 North America Hereditary Angioedema Treatment Sales Breakdown by Application
6.3.1 North America Hereditary Angioedema Treatment Sales Breakdown by Application (2016-2021)
6.3.2 North America Hereditary Angioedema Treatment Sales Breakdown by Application (2022-2027)
7 Europe Hereditary Angioedema Treatment Market Facts & Figures
7.1 Europe Hereditary Angioedema Treatment Sales by Company
7.1.1 Europe Hereditary Angioedema Treatment Sales by Company (2016-2021)
7.1.2 Europe Hereditary Angioedema Treatment Revenue by Company (2016-2021)
7.2 Europe Hereditary Angioedema Treatment Sales Breakdown by Type
7.2.1 Europe Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
7.3 Europe Hereditary Angioedema Treatment Sales Breakdown by Application
7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)
8 China Hereditary Angioedema Treatment Market Facts & Figures
8.1 China Hereditary Angioedema Treatment Sales by Company
8.1.1 China Hereditary Angioedema Treatment Sales by Company (2016-2021)
8.1.2 China Hereditary Angioedema Treatment Revenue by Company (2016-2021)
8.2 China Hereditary Angioedema Treatment Sales Breakdown by Type
8.2.1 China Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
8.2.2 China Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
8.3 China Hereditary Angioedema Treatment Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Hereditary Angioedema Treatment Market Facts & Figures
9.1 Japan Hereditary Angioedema Treatment Sales by Company
9.1.1 Japan Hereditary Angioedema Treatment Sales by Company (2016-2021)
9.1.2 Japan Hereditary Angioedema Treatment Revenue by Company (2016-2021)
9.2 Japan Hereditary Angioedema Treatment Sales Breakdown by Type
9.2.1 Japan Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
9.3 Japan Hereditary Angioedema Treatment Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Hereditary Angioedema Treatment Market Facts & Figures
10.1 Southeast Asia Hereditary Angioedema Treatment Sales by Company
10.1.1 Southeast Asia Hereditary Angioedema Treatment Sales by Company (2016-2021)
10.1.2 Southeast Asia Hereditary Angioedema Treatment Revenue by Company (2016-2021)
10.2 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Type
10.2.1 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Hereditary Angioedema Treatment Market Facts & Figures
11.1 India Hereditary Angioedema Treatment Sales by Company
11.1.1 India Hereditary Angioedema Treatment Sales by Company (2016-2021)
11.1.2 India Hereditary Angioedema Treatment Revenue by Company (2016-2021)
11.2 India Hereditary Angioedema Treatment Sales Breakdown by Type
11.2.1 India Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
11.2.2 India Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
11.3 India Hereditary Angioedema Treatment Sales Breakdown by Application
11.3.1 India Hereditary Angioedema Treatment Sales Breakdown by Application (2016-2021)
11.3.2 India Hereditary Angioedema Treatment Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Hereditary Angioedema Treatment Business
12.1 CSL
12.1.1 CSL Corporation Information
12.1.2 CSL Business Overview
12.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Hereditary Angioedema Treatment Products Offered
12.1.5 CSL Recent Development
12.2 Pharming Group
12.2.1 Pharming Group Corporation Information
12.2.2 Pharming Group Business Overview
12.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pharming Group Hereditary Angioedema Treatment Products Offered
12.2.5 Pharming Group Recent Development
12.3 Shire plc (Takeda Pharmaceutical Company Limited)
12.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
12.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
12.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Products Offered
12.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
12.4 Ionis Pharmaceuticals
12.4.1 Ionis Pharmaceuticals Corporation Information
12.4.2 Ionis Pharmaceuticals Business Overview
12.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Products Offered
12.4.5 Ionis Pharmaceuticals Recent Development
12.5 Attune Pharmaceuticals
12.5.1 Attune Pharmaceuticals Corporation Information
12.5.2 Attune Pharmaceuticals Business Overview
12.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Products Offered
12.5.5 Attune Pharmaceuticals Recent Development
12.6 BioCryst Pharmaceuticals
12.6.1 BioCryst Pharmaceuticals Corporation Information
12.6.2 BioCryst Pharmaceuticals Business Overview
12.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
12.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Products Offered
12.6.5 BioCryst Pharmaceuticals Recent Development
12.7 KalVista Pharmaceuticals
12.7.1 KalVista Pharmaceuticals Corporation Information
12.7.2 KalVista Pharmaceuticals Business Overview
12.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
12.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Products Offered
12.7.5 KalVista Pharmaceuticals Recent Development
...
13 Hereditary Angioedema Treatment Manufacturing Cost Analysis
13.1 Hereditary Angioedema Treatment Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hereditary Angioedema Treatment
13.4 Hereditary Angioedema Treatment Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hereditary Angioedema Treatment Distributors List
14.3 Hereditary Angioedema Treatment Customers
15 Market Dynamics
15.1 Hereditary Angioedema Treatment Market Trends
15.2 Hereditary Angioedema Treatment Drivers
15.3 Hereditary Angioedema Treatment Market Challenges
15.4 Hereditary Angioedema Treatment Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Hereditary Angioedema Treatment Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Hereditary Angioedema Treatment Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Hereditary Angioedema Treatment Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Hereditary Angioedema Treatment Sales (K Units) by Region (2016-2021)
Table 5. Global Hereditary Angioedema Treatment Sales Market Share by Region (2016-2021)
Table 6. Global Hereditary Angioedema Treatment Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Hereditary Angioedema Treatment Revenue Share by Region (2016-2021)
Table 8. Global Hereditary Angioedema Treatment Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Hereditary Angioedema Treatment Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Hereditary Angioedema Treatment Revenue Share Forecast by Region (2022-2027)
Table 12. Global Hereditary Angioedema Treatment Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Hereditary Angioedema Treatment Sales Share by Company (2016-2021)
Table 14. Global Hereditary Angioedema Treatment Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Hereditary Angioedema Treatment Revenue Share by Company (2016-2021)
Table 16. Global Hereditary Angioedema Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Treatment as of 2020)
Table 17. Global Hereditary Angioedema Treatment Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Hereditary Angioedema Treatment Manufacturing Sites and Area Served
Table 19. Manufacturers Hereditary Angioedema Treatment Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Hereditary Angioedema Treatment Sales (K Units) by Type (2016-2021)
Table 22. Global Hereditary Angioedema Treatment Sales Share by Type (2016-2021)
Table 23. Global Hereditary Angioedema Treatment Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Hereditary Angioedema Treatment Price (USD/Unit) by Type (2016-2021)
Table 25. Global Hereditary Angioedema Treatment Sales Share by Type (2022-2027)
Table 26. Global Hereditary Angioedema Treatment Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Hereditary Angioedema Treatment Revenue Share by Type (2022-2027)
Table 28. Global Hereditary Angioedema Treatment Price (USD/Unit) by Type (2022-2027)
Table 29. Global Hereditary Angioedema Treatment Sales (K Units) by Application (2016-2021)
Table 30. Global Hereditary Angioedema Treatment Sales Share by Application (2016-2021)
Table 31. Global Hereditary Angioedema Treatment Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Hereditary Angioedema Treatment Price (USD/Unit) by Application (2016-2021)
Table 33. Global Hereditary Angioedema Treatment Sales (K Units) by Application (2022-2027)
Table 34. Global Hereditary Angioedema Treatment Sales Share by Application (2022-2027)
Table 35. Global Hereditary Angioedema Treatment Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Hereditary Angioedema Treatment Revenue Share by Application (2022-2027)
Table 37. Global Hereditary Angioedema Treatment Price (USD/Unit) by Application (2022-2027)
Table 38. North America Hereditary Angioedema Treatment Sales (K Units) by Company (2016-2021)
Table 39. North America Hereditary Angioedema Treatment Sales Market Share by Company (2016-2021)
Table 40. North America Hereditary Angioedema Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Hereditary Angioedema Treatment Revenue Market Share by Company (2016-2021)
Table 42. North America Hereditary Angioedema Treatment Sales by Type (2016-2021) & (K Units)
Table 43. North America Hereditary Angioedema Treatment Sales Market Share by Type (2016-2021)
Table 44. North America Hereditary Angioedema Treatment Sales by Type (2022-2027) & (K Units)
Table 45. North America Hereditary Angioedema Treatment Sales Market Share by Type (2022-2027)
Table 46. North America Hereditary Angioedema Treatment Sales by Application (2016-2021) & (K Units)
Table 47. North America Hereditary Angioedema Treatment Sales Market Share by Application (2016-2021)
Table 48. North America Hereditary Angioedema Treatment Sales by Application (2022-2027) & (K Units)
Table 49. North America Hereditary Angioedema Treatment Sales Market Share by Application (2022-2027)
Table 50. Europe Hereditary Angioedema Treatment Sales (K Units) by Company (2016-2021)
Table 51. Europe Hereditary Angioedema Treatment Sales Market Share by Company (2016-2021)
Table 52. Europe Hereditary Angioedema Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Hereditary Angioedema Treatment Revenue Market Share by Company (2016-2021)
Table 54. Europe Hereditary Angioedema Treatment Sales by Type (2016-2021) & (K Units)
Table 55. Europe Hereditary Angioedema Treatment Sales Market Share by Type (2016-2021)
Table 56. Europe Hereditary Angioedema Treatment Sales by Type (2022-2027) & (K Units)
Table 57. Europe Hereditary Angioedema Treatment Sales Market Share by Type (2022-2027)
Table 58. Europe Hereditary Angioedema Treatment Sales by Application (2016-2021) & (K Units)
Table 59. Europe Hereditary Angioedema Treatment Sales Market Share by Application (2016-2021)
Table 60. Europe Hereditary Angioedema Treatment Sales by Application (2022-2027) & (K Units)
Table 61. Europe Hereditary Angioedema Treatment Sales Market Share by Application (2022-2027)
Table 62. China Hereditary Angioedema Treatment Sales (K Units) by Company (2016-2021)
Table 63. China Hereditary Angioedema Treatment Sales Market Share by Company (2016-2021)
Table 64. China Hereditary Angioedema Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Hereditary Angioedema Treatment Revenue Market Share by Company (2016-2021)
Table 66. China Hereditary Angioedema Treatment Sales by Type (2016-2021) & (K Units)
Table 67. China Hereditary Angioedema Treatment Sales Market Share by Type (2016-2021)
Table 68. China Hereditary Angioedema Treatment Sales by Type (2022-2027) & (K Units)
Table 69. China Hereditary Angioedema Treatment Sales Market Share by Type (2022-2027)
Table 70. China Hereditary Angioedema Treatment Sales by Application (2016-2021) & (K Units)
Table 71. China Hereditary Angioedema Treatment Sales Market Share by Application (2016-2021)
Table 72. China Hereditary Angioedema Treatment Sales by Application (2022-2027) & (K Units)
Table 73. China Hereditary Angioedema Treatment Sales Market Share by Application (2022-2027)
Table 74. Japan Hereditary Angioedema Treatment Sales (K Units) by Company (2016-2021)
Table 75. Japan Hereditary Angioedema Treatment Sales Market Share by Company (2016-2021)
Table 76. Japan Hereditary Angioedema Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Hereditary Angioedema Treatment Revenue Market Share by Company (2016-2021)
Table 78. Japan Hereditary Angioedema Treatment Sales by Type (2016-2021) & (K Units)
Table 79. Japan Hereditary Angioedema Treatment Sales Market Share by Type (2016-2021)
Table 80. Japan Hereditary Angioedema Treatment Sales by Type (2022-2027) & (K Units)
Table 81. Japan Hereditary Angioedema Treatment Sales Market Share by Type (2022-2027)
Table 82. Japan Hereditary Angioedema Treatment Sales by Application (2016-2021) & (K Units)
Table 83. Japan Hereditary Angioedema Treatment Sales Market Share by Application (2016-2021)
Table 84. Japan Hereditary Angioedema Treatment Sales by Application (2022-2027) & (K Units)
Table 85. Japan Hereditary Angioedema Treatment Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Hereditary Angioedema Treatment Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Hereditary Angioedema Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Hereditary Angioedema Treatment Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Hereditary Angioedema Treatment Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Hereditary Angioedema Treatment Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Hereditary Angioedema Treatment Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Hereditary Angioedema Treatment Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Application (2022-2027)
Table 98. India Hereditary Angioedema Treatment Sales (K Units) by Company (2016-2021)
Table 99. India Hereditary Angioedema Treatment Sales Market Share by Company (2016-2021)
Table 100. India Hereditary Angioedema Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Hereditary Angioedema Treatment Revenue Market Share by Company (2016-2021)
Table 102. India Hereditary Angioedema Treatment Sales by Type (2016-2021) & (K Units)
Table 103. India Hereditary Angioedema Treatment Sales Market Share by Type (2016-2021)
Table 104. India Hereditary Angioedema Treatment Sales by Type (2022-2027) & (K Units)
Table 105. India Hereditary Angioedema Treatment Sales Market Share by Type (2022-2027)
Table 106. India Hereditary Angioedema Treatment Sales by Application (2016-2021) & (K Units)
Table 107. India Hereditary Angioedema Treatment Sales Market Share by Application (2016-2021)
Table 108. India Hereditary Angioedema Treatment Sales by Application (2022-2027) & (K Units)
Table 109. India Hereditary Angioedema Treatment Sales Market Share by Application (2022-2027)
Table 110. CSL Corporation Information
Table 111. CSL Description and Business Overview
Table 112. CSL Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. CSL Hereditary Angioedema Treatment Product
Table 114. CSL Recent Development
Table 115. Pharming Group Corporation Information
Table 116. Pharming Group Description and Business Overview
Table 117. Pharming Group Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Pharming Group Hereditary Angioedema Treatment Product
Table 119. Pharming Group Recent Development
Table 120. Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
Table 121. Shire plc (Takeda Pharmaceutical Company Limited) Description and Business Overview
Table 122. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product
Table 124. Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
Table 125. Ionis Pharmaceuticals Corporation Information
Table 126. Ionis Pharmaceuticals Description and Business Overview
Table 127. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product
Table 129. Ionis Pharmaceuticals Recent Development
Table 130. Attune Pharmaceuticals Corporation Information
Table 131. Attune Pharmaceuticals Description and Business Overview
Table 132. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Attune Pharmaceuticals Hereditary Angioedema Treatment Product
Table 134. Attune Pharmaceuticals Recent Development
Table 135. BioCryst Pharmaceuticals Corporation Information
Table 136. BioCryst Pharmaceuticals Description and Business Overview
Table 137. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product
Table 139. BioCryst Pharmaceuticals Recent Development
Table 140. KalVista Pharmaceuticals Corporation Information
Table 141. KalVista Pharmaceuticals Description and Business Overview
Table 142. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product
Table 144. KalVista Pharmaceuticals Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Hereditary Angioedema Treatment Distributors List
Table 148. Hereditary Angioedema Treatment Customers List
Table 149. Hereditary Angioedema Treatment Market Trends
Table 150. Hereditary Angioedema Treatment Market Drivers
Table 151. Hereditary Angioedema Treatment Market Challenges
Table 152. Hereditary Angioedema Treatment Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Hereditary Angioedema Treatment Product Picture
Figure 2. Global Hereditary Angioedema Treatment Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Others (online pharmacies, mail pharmacies) Examples
Figure 9. Global Hereditary Angioedema Treatment Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hereditary Angioedema Treatment Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Hereditary Angioedema Treatment Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Hereditary Angioedema Treatment Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Hereditary Angioedema Treatment Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Hereditary Angioedema Treatment Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Hereditary Angioedema Treatment Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Hereditary Angioedema Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Hereditary Angioedema Treatment Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Hereditary Angioedema Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Hereditary Angioedema Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Hereditary Angioedema Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Hereditary Angioedema Treatment Players Market Share by Revenue in Hereditary Angioedema Treatment: 2016 & 2020
Figure 28. Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Hereditary Angioedema Treatment Revenue Share by Type (2016-2021)
Figure 30. Global Hereditary Angioedema Treatment Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Hereditary Angioedema Treatment Revenue Share by Application (2016-2021)
Figure 32. Global Hereditary Angioedema Treatment Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Hereditary Angioedema Treatment Sales Market Share by Type in 2020
Figure 34. North America Hereditary Angioedema Treatment Sales Market Share by Application in 2020
Figure 35. Europe Hereditary Angioedema Treatment Sales Market Share by Type in 2020
Figure 36. Europe Hereditary Angioedema Treatment Sales Market Share by Application in 2020
Figure 37. China Hereditary Angioedema Treatment Sales Market Share by Type in 2020
Figure 38. China Hereditary Angioedema Treatment Sales Market Share by Application in 2020
Figure 39. Japan Hereditary Angioedema Treatment Sales Market Share by Type in 2020
Figure 40. Japan Hereditary Angioedema Treatment Sales Market Share by Application in 2020
Figure 41. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Type in 2020
Figure 42. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Application in 2020
Figure 43. India Hereditary Angioedema Treatment Sales Market Share by Type in 2020
Figure 44. India Hereditary Angioedema Treatment Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Hereditary Angioedema Treatment
Figure 47. Manufacturing Process Analysis of Hereditary Angioedema Treatment
Figure 48. Hereditary Angioedema Treatment Industrial Cha

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs